Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian F Gage

Showing results (101-110 of 139) with videos related to

Pageof 14
Sort By:
Thrombosis Research|February 20, 2025
Association between anticoagulant-related bleeding and mortality in patients with hematological malignancies and cancer-associated venous thromboembolismTzu-Fei Wang, Suhong Luo, Brian F Gage, et al.
The American Journal of Cardiology|January 12, 2005
Simplified peak power reserve in patients with an implantable cardioverter-defibrillator and advanced heart failureWilliam T Katsiyiannis, Alan D Waggoner, Benico Barzilai, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 21, 2016
Statins Are Associated With Reduced Mortality in Multiple MyelomaKristen Marie Sanfilippo, Jesse Keller, Brian F Gage, et al.
Trials|November 19, 2010
Statistical design of personalized medicine interventions: the Clarification of Optimal Anticoagulation through Genetics (COAG) trialBenjamin French, Jungnam Joo, Nancy L Geller, et al.
Journal of the American College of Cardiology|April 13, 2010
Warfarin genotyping reduces hospitalization rates results from the MM-WES (Medco-Mayo Warfarin Effectiveness study)Robert S Epstein, Thomas P Moyer, Ronald E Aubert, et al.
Journal of Thrombosis and Haemostasis : JTH|June 18, 2026
Time-to-Start of Anticoagulant Therapy and Mortality in Pulmonary EmbolismKelsey E Bria, Brian F Gage, Alejandra Gutierrez, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|September 15, 2005
Preference-based antithrombotic therapy in atrial fibrillation: implications for clinical decision makingMalcolm Man-Son-Hing, Brian F Gage, Alan A Montgomery, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|July 19, 2019
Derivation and Validation of a Risk Assessment Model for Immunomodulatory Drug-Associated Thrombosis Among Patients With Multiple MyelomaAng Li, Qian Wu, Suhong Luo, et al.
Journal of Thrombosis and Haemostasis : JTH|May 31, 2022
Standardization of risk prediction model reporting in cancer-associated thrombosis: Communication from the ISTH SSC subcommittee on hemostasis and malignancyKristen M Sanfilippo, Tzu-Fei Wang, Marc Carrier, et al.
Pharmacoepidemiology and Drug Safety|February 9, 2010
Validation of claims-based diagnostic and procedure codes for cardiovascular and gastrointestinal serious adverse events in a commercially-insured populationPeter M Wahl, Keith Rodgers, Sebastian Schneeweiss, et al.
Pageof 14

Showing results (101-110 of 139) with videos related to

Sort By:
Pageof 14
Thrombosis Research|February 20, 2025
Association between anticoagulant-related bleeding and mortality in patients with hematological malignancies and cancer-associated venous thromboembolismTzu-Fei Wang, Suhong Luo, Brian F Gage, et al.
The American Journal of Cardiology|January 12, 2005
Simplified peak power reserve in patients with an implantable cardioverter-defibrillator and advanced heart failureWilliam T Katsiyiannis, Alan D Waggoner, Benico Barzilai, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 21, 2016
Statins Are Associated With Reduced Mortality in Multiple MyelomaKristen Marie Sanfilippo, Jesse Keller, Brian F Gage, et al.
Trials|November 19, 2010
Statistical design of personalized medicine interventions: the Clarification of Optimal Anticoagulation through Genetics (COAG) trialBenjamin French, Jungnam Joo, Nancy L Geller, et al.
Journal of the American College of Cardiology|April 13, 2010
Warfarin genotyping reduces hospitalization rates results from the MM-WES (Medco-Mayo Warfarin Effectiveness study)Robert S Epstein, Thomas P Moyer, Ronald E Aubert, et al.
Journal of Thrombosis and Haemostasis : JTH|June 18, 2026
Time-to-Start of Anticoagulant Therapy and Mortality in Pulmonary EmbolismKelsey E Bria, Brian F Gage, Alejandra Gutierrez, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|September 15, 2005
Preference-based antithrombotic therapy in atrial fibrillation: implications for clinical decision makingMalcolm Man-Son-Hing, Brian F Gage, Alan A Montgomery, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|July 19, 2019
Derivation and Validation of a Risk Assessment Model for Immunomodulatory Drug-Associated Thrombosis Among Patients With Multiple MyelomaAng Li, Qian Wu, Suhong Luo, et al.
Journal of Thrombosis and Haemostasis : JTH|May 31, 2022
Standardization of risk prediction model reporting in cancer-associated thrombosis: Communication from the ISTH SSC subcommittee on hemostasis and malignancyKristen M Sanfilippo, Tzu-Fei Wang, Marc Carrier, et al.
Pharmacoepidemiology and Drug Safety|February 9, 2010
Validation of claims-based diagnostic and procedure codes for cardiovascular and gastrointestinal serious adverse events in a commercially-insured populationPeter M Wahl, Keith Rodgers, Sebastian Schneeweiss, et al.
Pageof 14